Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
oligoprogression
Description:
A pattern of cancer progression in which a limited number of metastatic sites worsen while other disease remains controlled.
Related topics:
Lung Cancer Treatments and Mutations (19%),
Lung Cancer Diagnosis and Treatment (15%),
Cancer Immunotherapy and Biomarkers (13%)
OpenAlex ID:
keywords/oligoprogression
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
2020
·
Matthias Guckenberger
, Yolande Lievens
, et al.
·
The Lancet Oncology
·
1,230
PDF
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline
2023
·
Puneeth Iyengar
, Sean All
, et al.
·
Practical Radiation Oncology
·
162
PDF
Treatment Landscape of Renal Cell Carcinoma
2023
·
Yu-Wei Chen
, Luke Wang
, et al.
·
Current Treatment Options in Oncology
·
158
PDF
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
2021
·
Patrick Cheung
, Samir Patel
, et al.
·
European Urology
·
134
Pattern of Failure Analysis in Metastatic EGFR-Mutant Lung Cancer Treated with Tyrosine Kinase Inhibitors to Identify Candidates for Consolidation Stereotactic Body Radiation Therapy
2015
·
Hani Al-Halabi
, Karl Sayegh
, et al.
·
Journal of Thoracic Oncology
·
131
Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies
2023
·
Suna Zhou
, Haihua Yang
·
Frontiers in Immunology
·
122
PDF
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
2019
·
P.H. Patel
, D. Palma
, et al.
·
Clinical Oncology
·
120
PDF
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
2018
·
Sabine Schmid
, Stefan Diem
, et al.
·
Cancer Immunology Immunotherapy
·
118
Stereotactic body radiotherapy for oligoprogressive cancer
2016
·
Patrick Cheung
·
British Journal of Radiology
·
98
Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies.
2015
·
Charles B Simone
, Stuart H Burri
, et al.
·
PubMed
·
95
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
2019
·
Nicholas D. Klemen
, Melinda Wang
, et al.
·
Journal for ImmunoTherapy of Cancer
·
85
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
2021
·
Stefania Bellone
, Dana M. Roque
, et al.
·
Cancer
·
82
PDF
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness
2020
·
Rosario Mazzola
, Giulio Francolini
, et al.
·
Clinical Genitourinary Cancer
·
80
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors
2020
·
Stephan Rheinheimer
, Claus-Peter Heussel
, et al.
·
Cancers
·
80
PDF
Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression ― Interim Analysis of the First Randomized Study of Stereotactic Body Radiotherapy in Patients With Oligoprogressive Metastatic Cancers of the Lung and Breast
2021
·
C.J. Tsai
, J.T. Yang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
71
Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter
2017
·
Joelle Helou
, Isabelle Thibault
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
70
Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases
2018
·
Darby Erler
, Drew Brotherston
, et al.
·
Radiotherapy and Oncology
·
69
The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis
2017
·
O.S.H. Chan
, V.H.F. Lee
, et al.
·
Clinical Oncology
·
69
PDF
Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer
2016
·
Meghan Campo
, Hani Al-Halabi
, et al.
·
The Oncologist
·
66
Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer
2021
·
Yanjun Xu
, Hui Li
, et al.
·
Frontiers in Oncology
·
63
PDF
Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non–small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation
2017
·
Bo Qiu
, Ying Liang
, et al.
·
Clinical Lung Cancer
·
63
Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer
2019
·
Charlien Berghen
, Steven Joniau
, et al.
·
European Urology Oncology
·
60
PDF
Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials
2016
·
Michael B. Bernstein
, Eric L. Chang
, et al.
·
Thyroid
·
55
Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy
2020
·
Tiantian Guo
, Jianjiao Ni
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
54
Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?
2018
·
Tomas Merino Lara
, Joelle Helou
, et al.
·
Lung Cancer
·
52
Show more works
View as search
Works count:
561
Citation count:
6,089
Year
Topic
Type